Buy Galantamine Hydrobromide (Galantamine Hbr) Powder Pure Nootropics For Brain Brain Enhancement Online CAS 1953-04-4
What is Galantamine?
Galantamine (Nivalin, Razadyne, Razadyne ER, Reminyl, Lycoremine) is used for the treatment of cognitive decline in mild to moderate Alzheimer’s disease and various other memory impairments.
In addition to uses in Alzheimer’s disease, galantamine has been used to treat myasthenia, myopathy, muscular dystrophy, and sensory and motor dysfunction associated with disorders of the central nervous system.
Galantamine Hydrobromide Basic Information
| Product Name: |
Galantamine Hydrobromide |
| Synonyms: |
NIVALIN;NIVALIN, HBR;4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-METHYL-6H-BENZOFURO[3A,3,2-EF][2]
BENZAZEPIN-6-OL HYDROBROMIDE;GALANTAMINE HBR;
GALANTAMINE HYDROBROMIDE;GALANTHAMIDE HYDROBROMIDE;GALANTHAMINE HBR;
GALANTHAMINE HYDROBROMIDE, Galantamine HBr |
| CAS: |
1953-04-4 |
| MF: |
C17H22BrNO3 |
| MW: |
368.27 |
| EINECS: |
217-780-5 |
Galantamine Hydrobromide Certificate of Analysis
| Product name |
Galantamine Hydrobromide |
| CAS No. |
1953-04-4 |
Outer Packing |
1kg/bag |
| Production date |
2018.1.30 |
Shelf life |
2020.1.29 |
| Standard adopted |
USP30 |
| Items of analysis |
Specification |
Results |
| Appearance |
White crystalline powder |
Complies |
| Identification |
IR HPLC |
Complies |
| Test for Bromide |
A yellow precipitate is formed indicating the presence of bromideions. |
Complies |
| Loss on Drying (%w/w,determined on 1.0g) |
Not more than 0.5% |
0.25% |
| Residue on Ignition (%w/w,determined on 1.0g) |
Not more than 0.1% |
0.06% |
| Solubility |
Soluble in 0.1N sodium hydroxide, sparingly soluble in water, very slightly soluble in alcohol,insoluble in n-propanol. |
Complies |
| Heavy metals |
Not more than 20 PPM |
Less than 20 PPM |
| Limit Of Galanthamine Enantiomer [(+)-Galanthamine] (By HPLC,%w/w) |
Not more than 0.01% |
Not detected |
| Norgalanthamine [USP:N-Desmethylgalantamine] |
Not more than 0.20% |
Not detected |
| Lycoramine[USP:Dihydrogalantamine] |
Not more than 0.35% |
0.13% |
| Glanthamine N-oxide |
Not more than 0.20% |
Below Limit of Quantification |
| Epigalanthamine |
Not more than 0.20% |
Below Limit of Quantification |
| Epigalanthamine |
Not more than 0.40% |
Below Limit of Quantification |
| O-Desmethylgalanthamine |
Not more than 0.20% |
Not detected |
| Narwedine |
Not more than 0.15% |
0.02% |
| Any other |
Not more than 0.10% |
Not detected |
| Total |
Not more than 1.0% |
0.17% |
| Assay |
98.0-102.0% |
99.77% |
| Toluene |
Not more than 890 ppm |
Below Limit of Quantification |
| Ethanol |
Not more than 5000 ppm |
377 |
| Tetrahydrofuran |
Not more than 500 ppm |
Not detected |
| Bromide Content |
Between 20.6 %and 22.8% |
21.7% |
| Particle Size(By Malvern Particle size analyzer, µm) |
D(v,0.1) |
29 µm |
| Particle Size(By Malvern Particle size analyzer, µm) |
D(v,0.5) |
102µm |
| Particle Size(By Malvern Particle size analyzer, µm) |
D(v,0.9) |
188µm |
| Conclusion |
Qualified |
Galantamine Usage
Galantamine is used to treat mild to moderate confusion (dementia) related to Alzheimer’s disease. It does not cure Alzheimer’s disease, but it may improve memory, awareness, and the ability to perform daily functions. This medication works by restoring the balance of certain natural substances (neurotransmitters) in the brain.
Galantamine Dosage
Take this medication by mouth with food, usually twice daily with the morning and evening meals, or as directed by your doctor. Drink plenty of fluids with this medication unless instructed otherwise. To lower your risk of side effects, your dosage will be gradually increased to your target dose. Your dosage is based on your medical condition and response to therapy. Do not take more than the maximum recommended dose of 24 milligrams per day.
